Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Citius Pharmaceuticals (CTXR) has a market cap of $26.683 million USD. According to our data, Citius Pharmaceuticals is ranked No.8481 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $26.68 M |
-21.25%
|
| Dec 31, 2024 | $33.88 M |
-78.86%
|
| Dec 29, 2023 | $0.16 B |
-4.18%
|
| Dec 30, 2022 | $0.17 B |
-48.70%
|
| Dec 31, 2021 | $0.33 B |
50.98%
|
| Dec 31, 2020 | $0.22 B |
0.00%
|
| Dec 31, 2019 | $0.22 B |
-1.92%
|
| Dec 31, 2018 | $0.22 B |
-72.63%
|
| Dec 29, 2017 | $0.80 B |
-42.94%
|
| Dec 30, 2016 | $1.41 B |
-76.00%
|
| Dec 31, 2015 | $5.88 B |
77.88%
|
| Dec 31, 2014 | $3.30 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
| Market Cap | = | CTXR Stock Price | * | CTXR Shares Outstanding |
| = | $3.15 | * | 8.47 M | |
| = | $26.68 M |